Intra-arterial chemotherapy for group C retinoblastoma with adjacent high-flow infantile hemangioma

Area of Science:

• Ophthalmology
• Pediatric Oncology
• Vascular Biology

Background:

• Intra-arterial chemotherapy (IAC) is an emerging treatment for retinoblastoma.
• This technique involves delivering chemotherapy directly to the eye via an artery.
• Understanding drug delivery dynamics is crucial for optimizing IAC efficacy and safety.

Observation:

• The authors report the first case of an infantile hemangioma causing abnormal blood flow during IAC for retinoblastoma.
• The patient was a 4-month-old girl with macular group C retinoblastoma.
• The hemangioma shunted a significant portion of the chemotherapy away from the central retinal artery.

Findings:

• Despite reduced drug delivery to the retina, excellent tumor response was observed.
• This suggests potential for therapeutic efficacy even with non-ideal drug distribution.
• The case highlights the importance of considering vascular anomalies in IAC procedures.

Implications:

• Further research into the pharmacokinetics and dose-response relationships of IAC is warranted.
• Optimizing IAC protocols may minimize chemotherapy exposure and potential side effects.
• This case underscores the need for individualized treatment approaches in pediatric eye cancers.